Al Altomari
2021
In 2021, Al Altomari earned a total compensation of $2.4M as Chairman & Chief Executive Officer at Agile Therapeutics, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $1,602,009 |
| Salary | $594,445 |
| Other | $30,376 |
| Total | $2,406,830 |
Altomari received $1.6M in option awards, accounting for 67% of the total pay in 2021.
Altomari also received $180K in non-equity incentive plan, $594.4K in salary and $30.4K in other compensation.
Rankings
In 2021, Al Altomari's compensation ranked 5,306th out of 12,415 executives tracked by ExecPay. In other words, Altomari earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,306 out of 12,415 | 57th |
Division Manufacturing | 2,232 out of 5,508 | 60th |
Major group Chemicals And Allied Products | 972 out of 2,378 | 59th |
Industry group Drugs | 866 out of 2,099 | 59th |
Industry Pharmaceutical Preparations | 623 out of 1,549 | 60th |
Source: SEC filing on April 29, 2022.
Altomari's colleagues
We found two more compensation records of executives who worked with Al Altomari at Agile Therapeutics in 2021.